Literature DB >> 1665203

Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors.

R M Lyons1, D A Miller, J L Graycar, H L Moses, R Derynck.   

Abstract

A murine fibroblast cell line (AKR-2B clone 84A) and an epithelial cell line (BALB/MK) were compared for their ability to bind different transforming growth factor-beta (TGF beta) species. The results of competitive binding assays indicated that the epithelial cells had a higher affinity for TGF beta than the fibroblasts. This difference may be the basis for the sensitivity of epithelial cells to much lower concentrations of TGF beta than fibroblasts. Affinity cross-linking studies showed that both cell types express the three cell surface TGF beta-binding molecules that have been previously described for a variety of cell types. The complexity of these cell surface binding proteins was further evaluated using all possible combinations of radiolabeled ligands in competition with each of the three unlabeled TGF beta species. Differences in the ability of specific TGF beta types to compete with radiolabeled TGF beta 2 for binding to the type I and II receptors were observed, with TGF beta 1 being more potent for epithelial cells, and TGF beta 2 being more potent for fibroblasts. In addition, a difference in the ability of different TGF beta species to compete the [125I]TGF beta 3 from epithelial cell surface receptors was apparent. TGF beta 2 was not able to compete with [125I]TGF beta 3 for binding to the type II receptor at any concentration tested, while TGF beta 1 and TGF beta 3 were about equally potent in competition for this receptor type. These differences in cell surface receptor binding of structurally and biologically similar molecules may reflect different functions for these molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665203     DOI: 10.1210/mend-5-12-1887

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

1.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

Authors:  Matt K Lee; Cécile Pardoux; Marie C Hall; Pierre S Lee; David Warburton; Jing Qing; Susan M Smith; Rik Derynck
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

2.  Sequence-specific 1H and 15N assignment and secondary structure of transforming growth factor beta3.

Authors:  E V Bocharov; M J Blommers; J Kuhla; T Arvinte; R Bürgi; A S Arseniev
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

3.  Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.

Authors:  Mary Karst; Genevieve Gorny; Rachelle J Sells Galvin; Merry Jo Oursler
Journal:  J Cell Physiol       Date:  2004-07       Impact factor: 6.384

4.  Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells.

Authors:  M D Johnson; C F Federspiel; L I Gold; H L Moses
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

Review 5.  TGF-beta3 and cancer: a review.

Authors:  H G Laverty; L M Wakefield; N L Occleston; S O'Kane; M W J Ferguson
Journal:  Cytokine Growth Factor Rev       Date:  2009-08-04       Impact factor: 7.638

6.  Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

Authors:  Erik V Verona; Yuping Tang; Thomas K Millstead; Andrew P Hinck; Joseph K Agyin; Lu-Zhe Sun
Journal:  Protein Eng Des Sel       Date:  2008-05-21       Impact factor: 1.650

7.  Transcriptome-based identification of new anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions [corrected].

Authors:  Marika Massaro; Rosanna Martinelli; Valentina Gatta; Egeria Scoditti; Mariangela Pellegrino; Maria Annunziata Carluccio; Nadia Calabriso; Tonia Buonomo; Liborio Stuppia; Carlo Storelli; Raffaele De Caterina
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 8.  TGFβ signaling networks in ovarian cancer progression and plasticity.

Authors:  Asha Kumari; Zainab Shonibare; Mehri Monavarian; Rebecca C Arend; Nam Y Lee; Gareth J Inman; Karthikeyan Mythreye
Journal:  Clin Exp Metastasis       Date:  2021-02-15       Impact factor: 5.150

9.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

10.  TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats.

Authors:  Zhen Chang; Yo Kishimoto; Ayesha Hasan; Nathan V Welham
Journal:  Dis Model Mech       Date:  2013-10-02       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.